IFP Advisors, Inc - HEPION PHARMACEUTICALS INC ownership

HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 31 filers reported holding HEPION PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of HEPION PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$1
-99.9%
10.0%0.00%
Q3 2022$1,0000.0%10.0%0.00%
Q2 2022$1,0000.0%10.0%0.00%
Q1 2022$1,00010.00%
Q2 2021$000.00%
Q1 2021$0
-100.0%
0
-100.0%
0.00%
Q4 2020$11,0005,0000.00%
Other shareholders
HEPION PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
PVG ASSET MANAGEMENT CORP 189,616$375,439,0001.17%
Ikarian Capital, LLC 1,365,059$2,703,0000.22%
Altium Capital Management LP 446,000$883,0000.20%
ASSET MANAGEMENT CORP /IL/ /ADV 91,500$181,0000.10%
Virtu Financial LLC 113,869$225,0000.02%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 10,000$20,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 155,069$307,0000.01%
McAdam, LLC 55,978$86,0000.01%
Moloney Securities Asset Management, LLC 27,340$54,0000.01%
Allen Capital Group, LLC 23,685$47,0000.01%
View complete list of HEPION PHARMACEUTICALS INC shareholders